Massive study reveals hidden genetic markers in Hard-to-Treat cancers
NCT ID NCT04010240
First seen Oct 31, 2025 · Last updated Jun 14, 2026 · Updated 38 times
Summary
This study looked at nearly 4,000 people with advanced solid tumors to find out how often their cancers have a specific genetic change called an NTRK fusion. Researchers used advanced DNA and RNA testing on tumor samples to identify these fusions. The goal was to understand how common these changes are, which could help doctors choose targeted treatments in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC SOLID TUMORS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Institut Bergonié
Bordeaux, Aquitaine, 33000, France
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.